Ardent Health Partners (NYSE:ARDT) Sets New 12-Month Low – Should You Sell?

Shares of Ardent Health Partners, LLC (NYSE:ARDT) hit a new 52-week low during trading on Friday . The company traded as low as $13.07 and last traded at $13.16, with a volume of 591743 shares traded. The stock had previously closed at $13.93.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. JPMorgan Chase & Co. restated a “neutral” rating and issued a $20.00 price target on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Stephens reaffirmed an “overweight” rating and issued a $22.00 price target on shares of Ardent Health Partners in a report on Thursday, February 27th. Truist Financial cut their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Royal Bank of Canada lowered their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a report on Tuesday, March 4th. Finally, Morgan Stanley cut their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $21.18.

Ardent Health Partners Stock Performance

The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The business’s 50-day moving average is $14.58 and its two-hundred day moving average is $16.50.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.48 billion. Analysts forecast that Ardent Health Partners, LLC will post 1.23 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Charles Schwab Investment Management Inc. acquired a new stake in shares of Ardent Health Partners in the third quarter valued at about $526,000. BNP Paribas Financial Markets acquired a new stake in shares of Ardent Health Partners in the 3rd quarter worth approximately $42,000. MetLife Investment Management LLC acquired a new position in Ardent Health Partners during the third quarter worth $135,000. Goldentree Asset Management LP purchased a new stake in Ardent Health Partners during the third quarter worth $22,897,000. Finally, Centiva Capital LP purchased a new position in shares of Ardent Health Partners in the third quarter valued at $469,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.